Loading...
China SXT Pharmaceuticals, Inc.
SXTC•NASDAQ
Healthcare
Drug Manufacturers - Specialty & Generic
$1.59
$-0.03(-1.85%)
China SXT Pharmaceuticals, Inc. (SXTC) Financial Performance & Income Statement Overview
Review China SXT Pharmaceuticals, Inc.’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Revenue Growth
-2.19%
↓ 2.19%
Operating Income Growth
55.15%
↑ 55.15%
Net Income Growth
47.79%
↑ 47.79%
Operating Cash Flow Growth
-2287.47%
↓ 2287.47%
Operating Margin
691.04%
↑ 691.04%
Gross Margin
26.86%
↑ 26.86%
Net Profit Margin
667.16%
↑ 667.16%
ROE
47.36%
↑ 47.36%
ROIC
48.04%
↑ 48.04%
China SXT Pharmaceuticals, Inc. (SXTC) Income Statement & Financial Overview
Review China SXT Pharmaceuticals, Inc.'s (SXTC) income statement with detailed quarterly and annual figures.
| Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|
| Revenue | $494457.00 | $494457.00 | $939583.00 | $469792.00 |
| Cost of Revenue | $361642.00 | $361642.00 | $753992.00 | $325621.00 |
| Gross Profit | $132815.00 | $132815.00 | $185591.00 | $144171.00 |
| Gross Profit Ratio | $0.27 | $0.27 | $0.20 | $0.31 |
| R&D Expenses | $0.00 | $0.00 | $0.00 | $0.00 |
| SG&A Expenses | $3.50M | $3.50M | $9.53M | $4.82M |
| Operating Expenses | -$3.28M | -$3.28M | $9.53M | $4.82M |
| Total Costs & Expenses | -$2.92M | -$2.92M | $10.29M | $5.15M |
| Interest Income | $0.00 | $0.00 | $0.00 | $168260.00 |
| Interest Expense | $0.00 | $0.00 | $0.00 | $0.00 |
| Depreciation & Amortization | $50249.00 | $50249.00 | $102750.00 | $51375.00 |
| EBITDA | $3.68M | $3.68M | -$4.62M | -$4.62M |
| EBITDA Ratio | $7.44 | $7.44 | -$9.84 | -$9.84 |
| Operating Income | $3.42M | $3.42M | -$9.35M | -$4.67M |
| Operating Income Ratio | $6.91 | $6.91 | -$9.95 | -$9.95 |
| Other Income/Expenses (Net) | -$118089.00 | -$118089.00 | -$347138.00 | -$173568.00 |
| Income Before Tax | $3.30M | $3.30M | -$9.70M | -$4.85M |
| Income Before Tax Ratio | $6.67 | $6.67 | -$10.32 | -$10.32 |
| Income Tax Expense | $0.00 | $211462.00 | $0.00 | $0.00 |
| Net Income | $3.30M | $3.30M | -$9.70M | -$4.85M |
| Net Income Ratio | $6.67 | $6.67 | -$10.32 | -$10.32 |
| EPS | $2.67 | $2.67 | -$9.67 | -$9.67 |
| Diluted EPS | $2.67 | $2.67 | -$9.67 | -$9.67 |
| Weighted Avg Shares Outstanding | $1.23M | $1.23M | $501467.00 | $501467.00 |
| Weighted Avg Shares Outstanding (Diluted) | $1.23M | $1.23M | $501467.00 | $501467.00 |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan